Head and neck cancers

A new study has found that the level of a person’s immune cells may provide an indication of whether they would benefit from chemotherapy in oropharyngeal cancer.

The first proton beam therapy clinical trial in the UK is finding out if this innovative new form of radiotherapy can improve throat cancer treatment.

Some people with head and neck cancer will now have access to the immunotherapy drug pembrolizumab (Keytruda) on the NHS in England.   

Leukaemia and head and neck cancer drugs have not been recommended for NHS use in England.

Hyperbaric oxygen therapy has been used for years to prevent a side effect of head and neck cancer treatment called osteoradionecrosis. But does it work?

Standard chemotherapy remains the most effective way to treat a particular form of throat cancer, according to new research.

Men are more than twice as likely as women to develop oral cancer, according to new figures released by Cancer Research UK today (Wednesday).

A trial to test an experimental drug in patients with head and neck cancer launches in the UK through the Combinations Alliance.

An immunotherapy drug is too expensive to be given to NHS patients with head and neck cancers in England, according to the NHS drugs watchdog.

There’s more to stopping cancer from spreading than simply cutting out chocolate, despite what the headlines say.